• For every Novartis, which had four new drug approvals in 2001, there is a Bristol-Myers Squibb--which, despite making what appeared to be the right strategic moves, has not introduced a brand-new drug since 2000.

    FORBES: Magazine Article

  • Already Merck, Bristol-Myers Squibb and Schering-Plough are feeling the pinch as patent expirations loom over their aging arsenal.

    FORBES: Crisis in the Cabinet

  • Bristol-Myers Squibb and Sanofi-Aventis are in the midst of a legal fight with Apotex to protect Plavix's patent.

    ECONOMIST: Business this week

  • Prasugrel wasn't tested in the wide range of heart patients who get Plavix, which is sold by Bristol-Myers Squibb and Sanofi-Aventis.

    FORBES: Magazine Article

  • Big drug companies, including Pfizer, Bristol-Myers Squibb and Sanofi-Aventis, are doggedly pursuing drugs that aim to boost the immune system to fight cancer.

    FORBES: Magazine Article

  • Bristol-Myers Squibb ( BMY - news - people ) under the Taxol name.

    FORBES: Patrick Soon-Shiong and one of cancer's biggest riddles.

  • Bristol-Myers Squibb ( BMY - news - people ) sells a drug called Sprycel that competes with Tasigna.

    FORBES: Pipelines

  • Bristol-Myers Squibb ( BMY - news - people ) has been collaborating with Medarex for years but now will get full rights to the drug.

    FORBES: Health Care

  • Bristol-Myers Squibb ( BMY - news - people ) moved slightly higher after a federal panel said the company's diabetes drug appears free from the kinds of heart problems seen with similar drugs.

    FORBES: This is a transcript of the After Hours video report.

  • Bristol-Myers Squibb ( BMY - news - people ) learned that the Food and Drug Administration is extending until July 30 (from April 30) the time it is taking to review their application for the Type 2 diabetes treatment, saxagliptin, also known by its commercial name, Onglyza.

    FORBES: Stock Of The Week

  • All the women in Citron's study received a cocktail of cancer drugs, including Bristol-Myers Squibb 's (nyse: BMY - news - people ) Taxol, Bristol-Myers' Cytoxan and Pharmacia 's (nyse: PHA - news - people ) Adriamycin, all of which are available in generic forms.

    FORBES: Magazine Article

  • Bristol-Myers Squibb (nyse: BMY - news - people ) and GlaxoSmithkline are testing similar drugs.

    FORBES: Fat City

  • Pravachol, a Bristol-Myers Squibb (nyse: BMY - news - people) drug, takes most of the leftovers.

    FORBES: Magazine Article

  • Pravachol, made by Bristol-Myers Squibb (nyse: BMY - news - people ), is the next biggest.

    FORBES: Magazine Article

  • Barrow dumps stocks when they get too expensive, as Bristol-Myers Squibb (nyse: BMY - news - people) did.

    FORBES: Keep the Faith

  • Pargluva, from Bristol-Myers Squibb (nyse: BMY - news - people ), was never approved after such an analysis.

    FORBES: Open-Source Drug Safety?

  • Bristol-Myers Squibb (nyse: BMY - news - people) has gotten rid of both its orthopedics and beauty products divisions.

    FORBES: Magazine Article

  • And a committee recommended approval for Pargluva, a diabetes drug from Bristol-Myers Squibb (nyse: BMY - news - people ).

    FORBES: The Danger In Dendreon

  • One of these studies was not funded by Pfizer but by rival Bristol-Myers Squibb (nyse: BMY - news - people ).

    FORBES: Cholesterol Study Poses Dangers For Merck

  • Two new "super Gleevec" drugs are nearing the market--dasatinib from Bristol-Myers Squibb (nyse: BMY - news - people ) and nilotinib from Novartis.

    FORBES: The Race Is On

  • One of the companies that consistently missed its earlier consensus numbers is pharmaceuticals giant Bristol-Myers Squibb (nyse: BMY - news - people ).

    FORBES: Magazine Article

  • The last drug company to try and buy a potential blockbuster from a biotechnology company was Bristol-Myers Squibb (nyse: BMY - news - people ).

    FORBES: How Will Pharmacia Spend Its New Money?

  • Susan Desmond-Hellmann , head of product development at Genentech, helped develop Taxol when she was at Bristol-Myers Squibb (nyse: BMY - news - people ).

    FORBES: Chemotherapy's Juggernaut

  • But what is good news for patients makes for a tricky situation for ImClone and its partner Bristol-Myers Squibb (nyse: BMY - news - people ).

    FORBES: ImClone Gets Targeted

  • Chief Executive Stanley Crooke , 60, headed drug development at Smithkline Beckman and anti-cancer research at Bristol-Myers Squibb (nyse: BMY - news - people ).

    FORBES: Cholesterol Comeback

  • In PROVE-IT, presented two years ago, Lipitor proved better for treating very sick heart patients than Pravachol, from Bristol-Myers Squibb (nasdaq: BMY - news - people ).

    FORBES: Has Lipitor Reached Its Limit?

  • In a 1984 study, lowering LDL 12% with the Bristol-Myers Squibb (nyse: BMY - news - people ) drug Questran showed a benefit only after seven years.

    FORBES: The Statin Showdown

  • Susan Desmond-Hellmann , Levinson's second-in-command, helped develop the chemotherapy drug Taxol at Bristol-Myers Squibb (nyse: BMY - news - people ) before coming to Genentech in 1995.

    FORBES: Genentech's Next Act

  • With weaker statins, such as Pravachol from Bristol-Myers Squibb (nyse: BMY - news - people ) or lovastatin, available as a cheap generic, that requires the second-highest dose.

    FORBES: Cholesterol Guidelines A Gift For Merck, Pfizer

  • Also undergoing a brain transplant is Bristol-Myers Squibb (nyse: BMY - news - people ), which fired serial blunderer Peter Dolan and is still looking for a permanent replacement.

    FORBES: Taking Their Medicine

$firstVoiceSent
- 来自原声例句
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定